A model for p53-induced apoptosis

Article metrics

Abstract

The inactivation of the p53 gene in a large proportion of human cancers has inspired an intense search for the encoded protein's physiological and biological properties. Expression of p53 induces either a stable growth arrest or programmed cell death (apoptosis). In human colorectal cancers, the growth arrest is dependent on the transcriptional induction of the protein p21WAF1/CIP1(ref. 1), but the mechanisms underlying the development of p53-dependent apoptosis are largely unknown2. As the most well documented biochemical property of p53 is its ability to activate transcription of genes, we examined in detail the transcripts induced by p53 expression before the onset of apoptosis. Of 7,202 transcripts identified, only 14 (0.19%) were found to be markedly increased in p53-expressing cells compared with control cells. Strikingly, many of these genes were predicted to encode proteins that could generate or respond to oxidative stress, including one that is implicated in apoptosis in plant meristems. These observations stimulated additional biochemical and pharmacological experiments suggesting that p53 results in apoptosis through a three-step process: (1) the transcriptional induction of redox-related genes; (2) the formation of reactive oxygen species; and (3) the oxidative degradation of mitochondrial components, culminating in cell death.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Summary of SAGE data.
Figure 2: The PIG3 gene, illustrating intron–exon structure and promoter region.
Figure 3: Sequences of selected genes identified through SAGE.
Figure 4: Oxidative stress and mitochondrial damage in p53-mediated apoptosis.

References

  1. 1

    Waldman, T., Kinzler, K. W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187–5190 (1995).

  2. 2

    Oren, M. Relationship of p53 to the control of apoptotic cell death. Semin. Cancer Biol. 5, 221–227 (1994).

  3. 3

    Velculescu, V. E., Zhang, L., Vogelstein, B. & Kinzler, K. W. Serial analysis of gene expression. Science 270, 484–487 (1995).

  4. 4

    Polyak, K., Walkman, T., He, T.-C., Kinzler, K. W. & Vogelstein, B. Genetic determinants of p53 induced apoptosis and growth arrest. Genes Dev. 10, 1945–1952 (1966).

  5. 5

    Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323–331 (1997).

  6. 6

    Lehar, S. M.et al. Identification and cloning of Ei24, a gene induced by p53 in etoposide-treated cells. Oncogene 12, 1181–1187 (1996).

  7. 7

    Hayward, D. C.et al. The sluggish-A gene of Drosophila melanogaster is expressed in the nervous system and encodes proline oxidase, a mitochondrial enzyme involved in glutamate biosynthesis. Proc. Natl Acad. Sci. USA 90, 2979–2983 (1993).

  8. 8

    Russo, T.et al. Ap53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J. Biol. Chem. 270, 29386–29391 (1995).

  9. 9

    Reinhoff, H. Y. J, Huang, J. H., Li, X. X. & Liao, W. S. Molecular and cellular biology of serum amyloid A. Mol. Biol. Med. 7, 287–298 (1990).

  10. 10

    Yamaoka, A., Kuwabara, I., Frigeri, I. G. & Liu, F. T. Ahuman lectin, galectin-3 (epsilon bp/Mac-2) stimulates superoxide production by neutrophils. J. Immunol. 154, 3479–3487 (1995).

  11. 11

    Greenberg, J. T. Programmed cell death: A way of life for plants. Proc. Natl Acad. Sci. USA 93, 12094–12097 (1996).

  12. 12

    Rao, P. V., Krishna, C. M. & Zigler, J. S. J Identification and characterization of the enzymatic activity of zeta-crystallin from guinea PIG lens. A novel NADPH : quinone oxidoreductase. J. Biol. Chem. 267, 96–102 (1992).

  13. 13

    Kroemer, G., Zamzami, N. & Susin, S. A. Mitochondrial control of apoptosis. Immun. Today 18, 45–51 (1997).

  14. 14

    Zamzami, N.et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181, 1661–1672 (1995).

  15. 15

    Petit, P. X.et al. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell. Biol. 130, 157–167 (1995).

  16. 16

    Tamm, I. & Sehgal, P. B. Halobenzimidazole ribosides and RNA synthesis of cells and viruses. Adv. Virus Res. 22, 187–258 (1978).

  17. 17

    Orrenius, S., Nobel, C. S. I., van den Dobbelsteen, D. J., Burkitt, M. J. & Slater, A. F. G. Dithiocarbamates and the redox regulation of cell death. Biochem. Soc. Transact. 24, 1032–1038 (1996).

  18. 18

    Holland, P. C., Clark, M. G., Bloxham, D. P. & Lardy, H. A. Mechanism of action of the hypoglycemic agent diphenyleneiodonium. J. Biol. Chem. 248, 6050–6056 (1973).

  19. 19

    Korsmeyer, S. J. Regulators of cell death. Trends Genet. 11, 101–105 (1995).

  20. 20

    Susin, S. A.et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184, 1331–1341 (1996).

  21. 21

    Yang, J.et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129–1132 (1997).

  22. 22

    Kluck, R. M., Bossy-Wetzel, E., Green, D. R. & Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132–1136 (1997).

  23. 23

    Borek, C. Radiation and chemically induced transformation: free radicals, antioxidants and cancer. Br. J. Cancer suppl. 8, 74–86 (1987).

  24. 24

    Vayssiere, J. L., Petit, P. X., Risler, Y. & Mignotte, B. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc. Natl Acad. Sci. USA 91, 11752–11756 (1994).

  25. 25

    Johnson, T. M., Yu, Z.-X., Ferrans, V. J., Lowenstein, R. A. & Finkel, T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl Acad. Sci. USA 93, 11848–11852 (1996).

  26. 26

    El-Diery, W. S.et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).

  27. 27

    Velculescu, V. E.et al. Characterization of the yeast transcriptome. Cell 88, 243–251 (1997).

  28. 28

    El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W. & Vogelstein, B. Definition of a consensus binding site for p53. Nature Genet. 1, 45–49 (1992).

  29. 29

    Faulkner, K. & Fridovich, I. Luminol and lucigenin as detectors for O−2. Free Rad. Biol. Med. 15, 447–451 (1993).

Download references

Acknowledgements

We thank V. Velculescu, L. Zhang and W. Zhou for help with SAGE analysis; J. A. Duine for bongkrekic acid; J. Flook for assistance with flow cytometry; and members of our laboratories for discussion. This work was supported by the Clayton Fund and by grants from the NIH. K.P. is a research associate and B.V. is an investigator of the Howard Hughes Medical Institute.

Author information

Correspondence to Kornelia Polyak.

Rights and permissions

Reprints and Permissions

About this article

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.